Pharmafile Logo
Pharmafocus logo
Advanced Search

AbbVie

Showing 15 posts of 235 posts found.

Shire image

Shire buys rare-disease firm NPS Pharma

January 12, 2015
Sales and Marketing AbbVie, Shire, gattex, natpara, nps, nps pharma

Shire is to acquire rare diseases firm NPS Pharma to enhance its profile following the collapse of its deal with …

News
Abbvie

Abbvie Hep C drug gains FDA approval

December 22, 2014
Sales and Marketing AbbVie, FDA, Gilead, Viekira Pak, dasabuvir, harvoni, hepatitis, hepatits C

Abbvie has gained sign-off for its rival treatment to challenge Gilead’s dominance of the growing market for new hepatitis C …

News
Mylan image

Mylan shells out $32.5m to cover tax inversion fines

December 11, 2014
Sales and Marketing AbbVie, Abbott, Mylan, SEC, bresch, coury

Mylan will pay five of its top executives an early $32.5 million to cover penalties from the company’s plans to …

News
EMA image

EMA responds to redaction concerns

November 14, 2014
Sales and Marketing AbbVie, EMA, Goldacre, Humira, Rasi, adalimumab, redactions, transparency

The EMA has published a response to European Ombudsman Emily O’Reilly’s questions about some of its trial data redactions. O’Reilly’s …

News
Abbvie image

AbbVie financials beat expectations

October 31, 2014
Sales and Marketing AbbVie, Abbott, Creon, Humira, Iopinavir/ritonavir, Kaletra, Q3, Synthroid, levothyroxine, pancrelipase

AbbVie has announced higher-than-expected financial results for the third quarter of 2014, although it continues to rely heavily on blockbuster …

News
Google image

Google X developing diagnosis pill

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, Pfizer, calico, diagnosis pill, google, google x, vida, wearables

Google is developing a new pill designed to send microscopic particles into the bloodstream in an effort to identify cancers, …

News
james_bowling

Shire interim chief financial officer resigns

October 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Shire, james bowling, merger

Shire’s interim chief financial officer James Bowling has left the firm for water company Severn Trent following the collapse of …

Appointment
shire_image_1

AbbVie ditches Shire as tax deal falters

October 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Obama, Shire, US government, tax, tax inversion

Tax rule changes coming from the US government have forced the collapse of a multi-billion dollar deal between Humira manufacturer …

News
Abbvie image

AbbVie reconsiders Shire deal over tax laws

October 15, 2014
Medical Communications, Sales and Marketing AbbVie, Abbott, Obama, Shire, US, mergers, tax

AbbVie will reconsider its planned $54.6 billion takeover of Shire in light of new US proposals designed to curb companies …

News
EMA image

Mixed response to EMA data transparency plans

October 3, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, BMJ, Ben Goldacre, EMA, alltrials, transparency

The European Medicines Agency has passed new rules that will mandate pharma to release more of its clinical trial data …

News

Google’s Calico takes first steps into research

September 12, 2014
Medical Communications, Sales and Marketing AbbVie, P7C3, Parkinson's, Parkinson’s, calico, depression, google, motor neurone disease

Google is finally shifting into gear within the health arena as it signs its first research deal to develop a …

News
FTC building

Federal Trade Commission sues AbbVie and Teva

September 9, 2014
Manufacturing and Production, Sales and Marketing AbbVie, FTC, Teva, androgel, federal trade commission

Authorities in the US claim that AbbVie and Teva filed ‘sham’ lawsuits in a complicated pay-to-delay case for generic forms …

News
Infinity image

AbbVie and Infinity sign cancer deal

September 4, 2014
Research and Development, Sales and Marketing AbbVie, IPI-145, blood cancer, duvelisib, infinity

AbbVie has partnered with US company Infinity Pharmaceuticals to develop and commercialise the latter firm’s blood cancer treatment duvelisib (IPI-145). …

News
Google image

Google partners with AbbVie on ageing

September 4, 2014
Medical Communications, Research and Development, Sales and Marketing 23andME, AbbVie, Abbott, Roche, calico, google

Google’s healthcare company Calico has signed its first pharma pact with US firm AbbVie in a deal that could be …

News
Shire logo

AbbVie/Shire deal under threat from tax laws

August 7, 2014
Medical Communications, Sales and Marketing AbbVie, AstraZeneca, Pfizer, Shire, tax inversion

The £32 billion deal between AbbVie and Irish specialist biotech Shire could be under threat from new rules in the …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026